Mesoporous silica nanoparticles (MSNs) are a novel nanostructured drug delivery system. Monodisperse silica microspheres have pore sizes ranging from 2 to 50 nm, making them ideal for a variety of biological applications. They have unique properties such as tunable surface area, good surface characteristics and the ability to improve pharmacokinetic properties of drugs. In addition, the large number of pores allows drug incorporation and transport of drugs to various sites, making monodisperse silica microspheres a viable platform for oral drug delivery.
Fig.1 Types of mesoporous silica nanoparticles. (Sreeharsha et al., 2022)
CD Formulation offers mesoporous silica nanoparticle drug delivery services for the adsorption and delivery of proteins, enzymes, antibodies and nucleic acids, etc. We are proud to offer our customers customization and functionalization services for silica nanoparticles to help them better develop their drugs.
CD Formulation offers customization services for silica-based oral drug delivery systems including non-porous silica nanoparticles, mesoporous silica nanoparticles, hybridized silica nanoparticles and diatomic silica nanoparticles.
CD Formulation allows functionalized modification of mesoporous silica nanoparticles by assembling functional substances into the mesoporous pore channels of the particles. The surface of mesoporous silicon oxide nanoparticles is rich in The applied silica hydroxyl groups can easily interact with other organic functional groups and thus graft the organic functional groups onto the pore walls of the particles by covalent bonding. Our professional researchers can introduce functional groups such as amino groups, alkyl groups, sulfhydryl groups, carboxylic acids, thiols and transition metal complexes into mesoporous pore channels in the pores.
CD Formulation provides integrated innovation solutions from strategy to implementation to help you increase opportunities and address challenges. Through our in-depth experience in many different industries, including consumer and technology, we bring innovative solutions and cross-industry best practices to drug development. If you have a requirement about our services, please contact us by phone or email, our colleagues will reply to you within three working days.